Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Int J Neurosci ; 117(7): 1029-37, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17613112

RESUMEN

Recent studies indicate beneficial effects of acupuncture in the rehabilitation of vascular dementia (VaD). This study used 18-flourodeoxyglucose PET measures to compare cerebral effects of conventional acupuncture for hemiplegia with that of additional VaD-specific needling. As compared to baseline, conventional acupuncture increased glucose metabolism in the temporal lobe of unaffected and in the lentiform nucleus of the affected hemisphere. Additional needling in VaD-specific points rendered higher metabolism bilaterally in the frontal lobes and the thalamus, and in the temporal lobe and the lentiform nucleus of the unaffected hemisphere. The findings further underpin acupuncture's role in stroke and VaD rehabilitation.


Asunto(s)
Terapia por Acupuntura/métodos , Glucemia/metabolismo , Corteza Cerebral/metabolismo , Demencia Vascular/metabolismo , Hemiplejía/terapia , Accidente Cerebrovascular/metabolismo , Puntos de Acupuntura , Anciano , Corteza Cerebral/fisiopatología , Cuerpo Estriado/metabolismo , Cuerpo Estriado/fisiopatología , Demencia Vascular/etiología , Demencia Vascular/terapia , Femenino , Lateralidad Funcional , Hemiplejía/etiología , Hemiplejía/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Tomografía de Emisión de Positrones , Accidente Cerebrovascular/complicaciones , Accidente Cerebrovascular/terapia , Tálamo/metabolismo , Tálamo/fisiopatología
2.
Clin Rehabil ; 13(5): 384-91, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10498345

RESUMEN

OBJECTIVES: To test the effects of 200 IU/day of a nasal spray of salmon calcitonin in modulating the increased bone tissue metabolism observed in hemiplegic patients. DESIGN: A two-year, prospective, randomized, double-blind, placebo-controlled study. PATIENTS: Thirty-four patients with hemiplegia due to a cerebrovascular accident were included in the study during the first month after onset of hemiplegia after giving their informed consent. All patients followed a suitably planned course of active rehabilitation according to Bobath. They were randomly allocated to either the calcitonin or the placebo group but all of them received a daily oral calcium supplementation of 1000 mg. RESULTS: Biochemical markers of bone formation, serum total alkaline phosphatase, osteocalcin and type I procollagen did not vary during the two years of follow-up. Cross-linked carboxy-terminal telopeptide of type I collagen, a biochemical marker of bone resorption, was elevated initially after stroke and then decreased significantly (p <0.001), stabilizing as of month 12. Urinary calcium/creatinine and total hydroxyproline/creatinine ratios presented with similar profiles. The serum levels of the type III procollagen, a marker of connective tissue metabolism, were also elevated upon entry and decreased thereafter. No significant difference could be found between the calcitonin-treated and the placebo group for any of the biochemical markers at any time point. CONCLUSION: This prospective study demonstrated that biochemical markers of bone and connective tissue metabolism were elevated shortly after the occurrence of stroke and then gradually decreased during the first two years after injury. The daily administration of 200 IU of intranasal calcitonin did not influence the levels of these markers.


Asunto(s)
Resorción Ósea/prevención & control , Huesos/metabolismo , Calcitonina/farmacología , Tejido Conectivo/metabolismo , Hemiplejía/metabolismo , Accidente Cerebrovascular/metabolismo , Administración Intranasal , Anciano , Resorción Ósea/fisiopatología , Calcitonina/administración & dosificación , Método Doble Ciego , Femenino , Hemiplejía/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Accidente Cerebrovascular/complicaciones
3.
J Neurol Sci ; 129(2): 214-22, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7608738

RESUMEN

Familial hemiplegic migraine (FHM) is a rare autosomal dominant disorder of unknown pathogenesis characterized by migraine and transitory hemiplegic attacks. We describe a kindred fulfilling the diagnostic criteria for FHM in which: (1) brain phosphorus magnetic resonance spectroscopy (31P-MRS) showed a reduced phosphocreatine content accompanied by high [ADP], high percentage of V/Vmax of ATP biosynthesis and decreased phosphorylation potential; (2) muscle 31P-MRS showed a reduced rate of phosphocreatine recovery after exercise; (3) blood lactate was increased after effort; (4) muscle biopsy showed, in one patient, rare ragged red fibers succinate-dehydrogenase positive and cytochrome c oxidase negative; (5) genetic analysis of muscle mitochondrial DNA did not show any of the two point mutations in the tRNA(Leu(UUR)) associated with the MELAS syndrome (Mitochondrial myopathy, Encephalopathy with Lactic Acidosis and Stroke-like episodes). The defective energy metabolism of brain and muscle found in this pedigree suggests a multisystemic disorder of mitochondrial function in this FHM pedigree.


Asunto(s)
Encéfalo/metabolismo , Metabolismo Energético/fisiología , Hemiplejía/metabolismo , Trastornos Migrañosos/metabolismo , Músculo Esquelético/metabolismo , Adolescente , Adulto , Biopsia , Estudios de Casos y Controles , Femenino , Hemiplejía/genética , Humanos , Espectroscopía de Resonancia Magnética , Masculino , Persona de Mediana Edad , Trastornos Migrañosos/genética , Mitocondrias/metabolismo , Músculo Esquelético/patología , Linaje , Fósforo , Valores de Referencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA